FREEPORT-MCMORAN INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FREEPORT-MCMORAN INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.92B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $25.46B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $22.86B | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $22.78B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $22.85B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $14.20B | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $3.91B | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $3.15B | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $3.55B | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $3.79B | Feb 14, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.19B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $25.17B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $22.70B | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $23.27B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $22.42B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $13.89B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $14.35B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $18.95B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $15.89B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $14.56B | Feb 15, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $3.80B | Feb 26, 2016 |
| FY2015 | Sep 30, 2015 | $3.68B | Feb 26, 2016 |
| FY2015 | Jun 30, 2015 | $4.25B | Feb 26, 2016 |
| FY2015 | Mar 31, 2015 | $4.15B | Feb 26, 2016 |
| FY2015 | Dec 31, 2014 | $5.24B | Feb 26, 2016 |
| FY2015 | Sep 30, 2014 | $5.70B | Feb 26, 2016 |
| FY2015 | Jun 30, 2014 | $5.52B | Feb 26, 2016 |
| FY2015 | Mar 31, 2014 | $4.99B | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $5.89B | Feb 27, 2015 |
| FY2014 | Sep 30, 2013 | $6.17B | Feb 27, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.52B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.86B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.23B | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $7.04B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $8.37B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $2.44B | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $775.00M | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | ($38.00M) | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $33.00M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $321.00M | Feb 14, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $545.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $513.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $479.00M | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $420.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $383.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $370.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $394.00M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $422.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $477.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $597.00M | Feb 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.61B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $7.16B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $5.28B | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $5.14B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $7.72B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $3.02B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $1.48B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $3.86B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $4.67B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $3.74B | Feb 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.17B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $54.85B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $52.51B | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $51.09B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $48.02B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $42.14B | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $40.81B | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $42.22B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $37.30B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $37.32B | Feb 15, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.40B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $26.07B | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $25.20B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $26.22B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $25.00B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $23.48B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $23.36B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $24.32B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $26.01B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $28.06B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.90B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $17.58B | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $16.69B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $15.56B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $13.98B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $10.17B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $9.30B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $9.80B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $7.98B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $6.05B | Feb 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2014 | $0 | Feb 24, 2017 |
| FY2015 | Jun 30, 2014 | $1.94B | Feb 26, 2016 |
| FY2016 | Dec 31, 2013 | $1.92B | Feb 24, 2017 |
| FY2013 | Dec 31, 2012 | $0 | Feb 27, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($170.00M) | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | ($2.06B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($3.91B) | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($7.38B) | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | ($11.68B) | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | ($12.28B) | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | ($12.04B) | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | ($14.72B) | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | ($16.54B) | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.82B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $3.92B | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $4.76B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $8.15B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $8.07B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $3.66B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.02B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $4.22B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.53B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $4.25B | Feb 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.38B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $8.95B | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $9.42B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $10.62B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $9.45B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $9.71B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $9.83B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $11.14B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $2.23B | Feb 15, 2019 |
| FY2016 | Dec 30, 2016 | $2.23B | Feb 24, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 2 | Feb 15, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 15, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 14, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 14, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Feb 14, 2020 |
| FY2019 | Mar 31, 2018 | 0 | Feb 14, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 2 | Feb 15, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 15, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 14, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 14, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Feb 14, 2020 |
| FY2019 | Mar 31, 2018 | 0 | Feb 14, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | 945.00M | Feb 27, 2012 |
| FY2010 | Dec 31, 2010 | 945.00M | Feb 25, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $865.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $865.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $863.00M | Feb 13, 2026 |
| FY2023 | Dec 31, 2022 | $866.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $331.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $73.00M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $291.00M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $218.00M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $2.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $6.00M | Feb 15, 2019 |